| Literature DB >> 24283290 |
Xing-Hua Liao1, Da-Lin Lu, Nan Wang, Long-Yue Liu, Yue Wang, Yan-Qi Li, Ting-Bao Yan, Xue-Guang Sun, Peng Hu, Tong-Cun Zhang.
Abstract
High expression of estrogen receptor α (ERα) is associated with a poor prognosis that correlates closely with cellular proliferation in breast cancer. However, the exact molecular mechanism by which ERα controls breast cancer cell proliferation is not clear. Here we report that ERα regulates the cell cycle by suppressing p53/p21 and up-regulating proliferating cell nuclear antigen (PCNA) and proliferation-related Ki-67 antigen (Ki-67) to promote proliferation of MCF-7 cells. In addition, 17-β-estradiol (E2) enhances ERα-induced proliferation of MCF-7 cells by stimulating expression of PCNA and Ki-67. Knockdown of ERα significantly affects PCNA/Ki-67 and p53/p21 expression. Furthermore, ERα inhibits the transcriptional activity of p53/p21 in an estrogen response element-dependent manner. More importantly, we provide new evidence that ERα mediates proliferation of MCF-7 cells by up-regulating miR-17 to silence the expression of p21. Thus, these data provide new insights into the underlying effect of ERα on breast cancer proliferation.Entities:
Keywords: MCF-7 cell proliferation; PCNA; estrogen receptor α (ERα); miR-17; p21
Mesh:
Substances:
Year: 2014 PMID: 24283290 DOI: 10.1111/febs.12658
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542